Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-IMG-23796

Xenbase Image ID: 23796

Fig. 7. XHRT1 reverses the effect of Su(H)DBM on Evi1 but is not sufficient to restore XSMP-30 expression. (A-H) Late tailbud/early tadpole stage embryos injected with 500 pg of Su(H)DBM mRNA together with 500 pg of XHRT1a-mut-MT-hGR mRNA, untreated (A-D) or dexamethasone treated (E-H) at stage 22.β -galactosidase RNA was co-injected to identify the injected side. Note the decrease of XSMP-30 and the increase of Evi1 expression in untreated embryos, and the reduction of both XSMP-30 and Evi1 expression in treated embryos. (I) Quantification of the results. Embryos were classified into two phenotypes (increase Evi1 and decrease XSMP-30). n, number of cases analysed.

Image published in: Taelman V et al. (2006)

Copyright © 2006. Image reproduced with permission of the publisher and the copyright holder. This is an Open Access article distributed under the terms of the Creative Commons Attribution License.

GeneSynonymsSpeciesStage(s)Tissue
rgnregucalcin, smp30, xsmp-30, xsmp30XenopusSometime during NF stage 29 and 30 to NF stage 66early proximal tubule
late proximal tubule
mecomecotropic viral integration site 1, evi-1, evi1, mecom-a, mecom-b, xEvi-1XenopusSometime during NF stage 29 and 30 to NF stage 66early distal tubule
late distal tubule
pronephric duct

Image source: Published

Larger Image
Printer Friendly View

Return to previous page